Pharmaceutical News Feed (10 сообщений)

[nimibaht]

Pharmaceutical News Feed (10 сообщений)


 Pharmaceutical News Feed
Latest Pharmaceutical News and Research
http://www.news-medical.net/
рекомендовать друзьям >>

• Watson's Colesevelam HCI cialis seek FDA approval
  Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Colesevelam HCI 625 mg tablets.
  
  Переслать
  
  
• Salix Pharmaceuticals receives three U.S. patents in relation to rifaximin
  Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the U.S. Patent and Trademark Office has issued three patents relating to rifaximin.
  
  Переслать
  
  
• Report: Prescription drug spending growth slows
  Americans and their insurers spent $307.4 billion on prescription drugs in 2010, up just 2.3 percent from the previous year, according to data released Tuesday by IMS Health Inc.
  
  Переслать
  
  
• Neurelis completes dosing in intranasal diazepam formulation study
  Neurelis, Inc. today announced the completion of subject dosing in a randomized crossover study assessing diazepam pharmacokinetics and bioavailability after administration of two proprietary formulations of intranasal diazepam and intravenous injection.
  
  Переслать
  
  
• Feds announce comprehensive plan to combat painkiller abuse
  The new strategy will put increased pressure on the state of Florida, which has a reputation as being "the nation's pill mill."
  
  Переслать
  
  
• Shanghai Pharmaceutical and Pfizer enter MOU to pursue potential business opportunities
  Shanghai Pharmaceutical Co. Ltd. and Pfizer Inc. today announced the signing of a memorandum of understanding (MOU) for the companies to jointly pursue potential business opportunities in China.
  
  Переслать
  
  
• America's best loved drugs: Report
  According to the latest report from consulting firm IMS Health, Americans are consuming a lot of prescription drugs. And they seem especially fond of those to lower their cholesterol, relieve heartburn, aid in depressive disorders and lessen pain. Overall, however, their spending on such drugs is slowing.
  
  Переслать
  
  
• Stepped up measures to tack rising painkiller abuse
  Prescription drug abuse is one of the largest problems in the country say experts and according to White House drug Czar Gil Kerlikowske, the Congress must require special training for doctors and other health care workers before they are allowed to prescribe powerful drugs such as OxyContin.
  
  Переслать
  
  
• Prism Pharmaceuticals to be acquired by Baxter
  Ligand Pharmaceuticals Incorporated announced that its partner Prism Pharmaceuticals has entered into a definitive agreement to be acquired by Baxter International Inc.. Prism Pharmaceuticals recently received FDA approval for Nexterone®, an antiarrhythmic agent which Ligand (through its CyDex Pharmaceuticals subsidiary) originally developed with its patented Captisol® formulation technology and licensed to Prism in 2006.
  
  Переслать
  
  
• Treatment for Bipolar Disorder now available in Nova Scotia Formulary
  The Nova Scotia Department of Health and Wellness has approved the listing of LITHMAX (Lithium Carbonate Sustained-Release 300mg Tablets) in the Nova Scotia Formulary, effective April 19th, 2011. This announcement comes as welcome news to patients in need of the sustained-release formulation of Lithium Carbonate who require help to pay for prescribed medications.
  
  Переслать
  
  

Записки опытного ЖЖ-шника о SEO


Только авторские статьи о продвижении сайтов и заработке в интернете. О seo просто и доступно!
Присоединиться →

rss2email.ru rss2email.ru       Ð¾Ñ‚писаться: http://www.rss2email.ru/unsubscribe.asp?c=92256&u=766634&r=574575452
управление подпиской: http://www.rss2email.ru/manage.asp
партнерская программа: http://partner.rss2email.ru/?pid=1